We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current EKSO market cap is 26.14M. The company's latest EPS is USD -0.8423 and P/E is -1.69.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 3.33M | 3.55M | 4.12M | 4.7M | 4.61M |
Operating Income | -3.65M | -4.44M | -4.45M | -4.28M | -2.93M |
Net Income | -4.3M | -3.18M | -4.39M | -4.23M | -3.37M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 11.37M | 13.92M | 8.88M | 11.25M | 12.91M |
Operating Income | -27.03M | -16.64M | -13.29M | -14.71M | -15.56M |
Net Income | -26.99M | -12.13M | -15.83M | -9.76M | -15.08M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 39.31M | 40.9M | 37.1M | 33.99M | 31.18M |
Total Liabilities | 10.7M | 15.46M | 15.82M | 16.18M | 15.93M |
Total Equity | 28.61M | 25.44M | 21.28M | 17.81M | 15.26M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 17.66M | 21.92M | 20.6M | 49.17M | 40.9M |
Total Liabilities | 14.93M | 15.12M | 16.16M | 11.95M | 15.46M |
Total Equity | 2.73M | 6.8M | 4.43M | 37.22M | 25.44M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -11.04M | -14.69M | -4.21M | -7.12M | -10.47M |
Investing | -141k | -5.18M | -42k | -97k | -114k |
Financing | N/A | N/A | N/A | N/A | N/A |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -22.17M | -15.77M | -8.76M | -11.16M | -14.69M |
Investing | -131k | -60k | N/A | -59k | -5.18M |
Financing | 2.27M | 19.04M | 10.7M | 38.71M | N/A |
Market Cap | 26.14M |
Price to Earnings Ratio | -1.69 |
Price to Sales Ratio | 1.97 |
Price to Cash Ratio | 1.24 |
Price to Book Ratio | 1 |
Dividend Yield | - |
Shares Outstanding | 17.9M |
Average Volume (1 week) | 78.48k |
Average Volume (1 Month) | 246.71k |
52 Week Change | -2.01% |
52 Week High | 3.1285 |
52 Week Low | 0.62 |
Spread (Intraday) | 0.06 (4.05%) |
Company Name | Ekso Bionics Holdings Inc |
Address |
8275 south eastern avenue las vegas, nevada 89123 |
Website | https://www.eksobionics.com |
Industry | general indl mach & eq, nec (3569) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions